doxapram has been researched along with Anoxia, Fetal in 2 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kobayashi, K | 1 |
Lemke, RP | 1 |
Greer, JJ | 1 |
Wilds, PL | 1 |
2 other studies available for doxapram and Anoxia, Fetal
Article | Year |
---|---|
Ultrasound measurements of fetal breathing movements in the rat.
Topics: Aminophylline; Animals; Doxapram; Fetal Hypoxia; Fetal Movement; Fetus; Gestational Age; Rats; Rats, | 2001 |
Observations of intrauterine fetal breathing movements--a review.
Topics: Adrenocorticotropic Hormone; Animals; Blood; Blood Glucose; Blood Pressure; Carbon Dioxide; Circadia | 1978 |